Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression
出版年份 2015 全文链接
标题
Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 21, Pages 13510-13520
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2015-04-07
DOI
10.1074/jbc.m114.622126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases
- (2014) Anja Rabenhorst et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Dual Modulation of Airway Smooth Muscle Contraction by Th2 Cytokines via Matrix Metalloproteinase-1 Production
- (2014) Y. Ohta et al. JOURNAL OF IMMUNOLOGY
- Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells
- (2014) M. S. Wilson et al. JOURNAL OF IMMUNOLOGY
- Human Th2 but Not Th9 Cells Release IL-31 in a STAT6/NF-κB–Dependent Way
- (2014) Elisabeth Maier et al. JOURNAL OF IMMUNOLOGY
- Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and Disease
- (2013) Steven J. Van Dyken et al. Annual Review of Immunology
- Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis
- (2013) Andrea J. Gonzales et al. VETERINARY DERMATOLOGY
- IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis
- (2012) GFL Hofbauer et al. ACTA DERMATO-VENEREOLOGICA
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Dendritic Cells Activated by IFN- /STAT1 Express IL-31 Receptor and Release Proinflammatory Mediators upon IL-31 Treatment
- (2012) J. Horejs-Hoeck et al. JOURNAL OF IMMUNOLOGY
- Signaling by IL-31 and functional consequences
- (2011) Christian Cornelissen et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice
- (2011) Charles Perkins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternative Activation of Macrophages: Mechanism and Functions
- (2010) Siamon Gordon et al. IMMUNITY
- Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis
- (2010) P. F.-Y. Cheung et al. INTERNATIONAL IMMUNOLOGY
- Matrix Metalloproteinase 12-Deficiency Augments Extracellular Matrix Degrading Metalloproteinases and Attenuates IL-13-Dependent Fibrosis
- (2010) S. K. Madala et al. JOURNAL OF IMMUNOLOGY
- IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M
- (2010) J. Bilsborough et al. JOURNAL OF IMMUNOLOGY
- Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins
- (2009) S. Kasraie et al. ALLERGY
- Retnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type Immunity
- (2009) John T. Pesce et al. PLoS Pathogens
- Structures and biological functions of IL-31 and IL-31 receptors
- (2008) Qing Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis
- (2008) Øystein Grimstad et al. EXPERIMENTAL DERMATOLOGY
- IL-31 Receptor Alpha Expression in Epidermal Keratinocytes Is Modulated by Cell Differentiation and Interferon Gamma
- (2008) Ruth Heise et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Distinct roles for IL-13 and IL-4 via IL-13 receptor 1 and the type II IL-4 receptor in asthma pathogenesis
- (2008) A. Munitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cationic Amino Acid Transporter-2 Regulates Immunity by Modulating Arginase Activity
- (2008) Robert W. Thompson et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More